Personas / Equipo Humano

Francesc Villarroya Gombau

Buscador de publicaciones

Publicaciones

  • Chung SY, Kao CH, Villarroya-Gombau F, Chang HY, Chang HC, Hsiao SP, Liou GG and Chen SL.

    Bhlhe40 Represses PGC-1a Activity on Metabolic Gene Promoters in Myogenic Cells.

    MOLECULAR AND CELLULAR BIOLOGY . 35(14): 2518-2529. Nº de citas: 17

    [doi:10.1128/MCB.00387-15]

  • Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escoté X, Gómez-Serrano M, Peral B, Salvadó L, Fernández-Veledo S, Casals N, Vazquez M, Villarroya-Gombau F, Vendrell JJ, Serra D and Herrero L.

    Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.

    AM J PHYSIOL-ENDOC M . 308(9): . Nº de citas: 143

    [doi:10.1152/ajpendo.00362.2014]

  • Sánchez-Infantes D, Gallego-Escuredo J, Díaz-Silva M, Aragonès G, Sebastiani G, López-Bermejo A, de Zegher F, Domingo P, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations

    INTERNATIONAL JOURNAL OF OBESITY . 39(5): 742-746. Nº de citas: 26

    [doi:10.1038/ijo.2015.2]

  • Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M and Villarroya-Gombau F.

    Fibroblast growth factor 21 protects the heart from oxidative stress.

    CARDIOVASCULAR RESEARCH . 106(1): 19-31. Nº de citas: 214

    [doi:10.1093/cvr/cvu263]

  • Cereijo R, Giralt M and Villarroya-Gombau F.

    Thermogenic brown and beige/brite adipogenesis in humans.

    ANNALS OF MEDICINE . 47(2): 169-177. Nº de citas: 69

    [doi:10.3109/07853890.2014.952328]

  • Sheedfar F, Vermeer M, Pazienza V, Villarroya-Terrade J, Rappa F, Cappello F, Mazzoccoli G, Villarroya-Gombau F, van der Molen H, Hofker MH, Koonen DP and Vinciguerra M.

    Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

    INTERNATIONAL JOURNAL OF OBESITY . 39(2): 331-338. Nº de citas: 19

    [doi:10.1038/ijo.2014.91]

  • Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya-Gombau F and Giralt M.

    Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Nº de citas: 11

    [doi:10.1093/jac/dkv027]

  • Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya-Gombau F, Frühbeck G, Fernández-Real JM and Malagón MM.

    Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in ß-cells.

    INTERNATIONAL JOURNAL OF OBESITY . 38(12): 1545-1554. Nº de citas: 76

    [doi:10.1038/ijo.2014.36]

  • Villarroya-Terrade J, Flachs P, Redondo-Angulo I, Giralt M, Medrikova D, Villarroya-Gombau F, Kopecky J and Planavila A.

    Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.

    Lipids . 49(11): 1081-1089. Nº de citas: 20

    [doi:10.1007/s11745-014-3948-x]

  • Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya-Gombau F, Serrano M, Fernø J, Salvador J, Escalada J, Dieguez C, Lopez M, Frühbeck G and Nogueiras R.

    GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.

    Diabetes . 63(10): 3346-3358. Nº de citas: 453

    [doi:10.2337/db14-0302]